Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Syros Pharmaceuticals (DE:0S9)
FRANKFURT:0S9
RESEARCH TOOLSreports
Syros Pharmaceuticals (0S9) Financial Statements
0 Followers
Syros Pharmaceuticals Financial Overview
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 6.28M | $ 5.47M | $ 7.80M | $ 5.70M | $ 5.16M |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -33.50M | $ -24.17M | $ -22.83M | $ -25.04M | $ -21.52M |
| EBITDA | $ -32.77M | $ -23.42M | $ -22.05M | $ -24.28M | $ -20.77M |
| Net Income Common Stockholders | $ -34.48M | $ -25.15M | $ -23.81M | $ -26.03M | $ -22.49M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 86.28M | $ 91.42M | $ 93.13M | $ 108.67M | $ 110.26M |
| Total Assets | $ 126.23M | $ 152.08M | $ 182.94M | $ 208.04M | $ 233.73M |
| Total Debt | $ 25.92M | $ 45.90M | $ 46.71M | $ 47.13M | $ 57.59M |
| Net Debt | $ -60.37M | $ -45.51M | $ -46.42M | $ -61.55M | $ -52.67M |
| Total Liabilities | $ 95.22M | $ 89.34M | $ 97.72M | $ 101.98M | $ 103.76M |
| Stockholders Equity | $ 31.02M | $ 45.94M | $ 62.41M | $ 62.74M | $ 76.54M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -26.29M | $ -30.14M | $ -23.21M | $ -28.44M | $ -26.88M |
| Operating Cash Flow | $ -26.18M | $ -30.02M | $ -22.97M | $ -28.13M | $ -26.45M |
| Investing Cash Flow | $ 15.89M | $ 7.38M | $ -245.00K | $ -17.30M | $ -34.84M |
| Financing Cash Flow | $ -222.00K | $ -93.00K | $ 96.00K | $ -67.00K | $ 72.00K |
Syros Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.